Ionis Pharmaceuticals Inc (IONS) stock news · $12.28B cap
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
This IONS news page leads with what Ionis Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for IONS yet. We will not pad this page with generic market recap.
Latest reported IONS revenue for 2026-06-30 was $267.9M. Net income was -$114.6M. Revenue was up 8.9% from 2026-03-31 to 2026-06-30. IONS currently screens at market cap $12.28B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IONS stock page; for the tape open the quote page.
IONS stock news FAQ
What are IONS's latest revenue and net income?
Latest cached Ionis Pharmaceuticals Inc (IONS) revenue for Jun 30, 2026 was $267.9M. Net income was -$114.6M. Statements: https://lician.com/financials/ions
How did IONS revenue change from the prior cached period?
Cached Ionis Pharmaceuticals Inc (IONS) revenue was up 8.9% from $246.1M (Mar 31, 2026) to $267.9M (Jun 30, 2026). Statements: https://lician.com/financials/ions
What is IONS's market cap?
Ionis Pharmaceuticals Inc (IONS) market cap is $12.28B on the latest cached fundamentals snapshot.
What kind of company is IONS?
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Where is IONS stock news listed?
Cached stock news for Ionis Pharmaceuticals Inc (IONS) is listed at https://lician.com/news/ions. Filings: https://lician.com/sec/ions
Not investment advice.